共 145 条
[11]
Havmoeller R(2017)Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation N Engl J Med 376 1627-1636
[12]
Narayanan K(2015)Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation Eur Heart J 36 1805-11
[13]
Choudhury A(2014)2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 e1-76
[14]
Lip GY(2019)2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 74 104-132
[15]
Kamel H(2019)Use of direct oral anticoagulants among patients with limited income and resources J Am Coll Cardiol 73 526-528
[16]
Okin PM(2017)Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation Eur Heart J 38 38-50
[17]
Elkind MS(2018)PAR1 contribution in acute electrophysiological properties of oral anticoagulants in rabbit pulmonary vein sleeve preparations Fundam Clin Pharmacol 32 378-391
[18]
Iadecola C(2015)Vitamin K: an old vitamin in a new perspective Dermatoendocrinol 6 e968490-32
[19]
Connolly SJ(2018)Effects of warfarin on biological processes other than haemostasis: a review Food Chem Toxicol 113 19-9557
[20]
Ezekowitz MD(2015)New insights into the pros and cons of the clinical use of vitamin K antagonists (VKAs) versus direct oral anticoagulants (DOACs) Nutrients 7 9538-66